EUVIMED · CrossrefJournal
Journal of Chemotherapy
ISSN 1120-009X · Informa UK Limited
Latest articles
Colorectal cancer management in the era of targeted and precision medicine: epidemiological trends, molecular insights and advanced delivery systems
An innovative perspective on targeted therapy for glioblastoma utilizing gemcitabine combined with tankyrase (TNKS) 1 inhibitor XAV939
Sex-related differences in time-to-onset of immune checkpoint inhibitor-related interstitial lung disease: a JADER pharmacovigilance study
Brigatinib plus carboplatin–pemetrexed after lorlatinib failure in ALK-rearranged non-small cell lung cancer with co-occurring ALK I1171N and G1269A mutations: a case report
Gefitinib in breast cancer: molecular rationale, clinical evidence, resistance mechanisms and future perspectives
Time-dependent indirect comparison of enfortumab vedotin plus pembrolizumab and disitamab vedotin plus toripalimab in advanced urothelial carcinoma
Integrative topological and longitudinal transcriptomic analyses identify a 14-gene interferon-stimulated module associated with acquired sunitinib resistance in clear cell renal cell carcinoma
Cefiderocol susceptibility in carbapenem-resistant Acinetobacter baumannii , Pseudomonas aeruginosa , and Stenotrophomonas maltophilia isolates: concordance of disk diffusion with the reference method and comparative analysis of CLSI-EUCAST criteria
Six-month progression-free survival-related tumor growth rate after upfront chemotherapy as an outcome measure and potential prognostic or stratification variable for patients with unresectable pancreatic adenocarcinoma: an exploratory study cohorts analysis
Pharmacogenomic biomarkers in oncology: evidence, clinical utility, and barriers to implementation
Clinical efficacy and safety profile of long-acting lipoglycopeptides versus daily intravenous antibiotics for acute bacterial skin and skin structure infections (ABSSSI): a retrospective study in Greece
Efficacy and safety of TROP2 antibody-drug conjugate-containing regimen in the patients with HER2 negative metastatic breast cancer and advanced non-small-cell lung cancer
A 1:1:1 propensity score matching design to account for center-specific antimicrobial treatment or prophylaxis in observational studies: the case of the POSACOVID study
Striking effectiveness of siltuximab-based treatment in refractory idiopathic multicentric Castleman disease resembling IgG4-related disease
Research progress on eravacycline: from pharmacokinetics/pharmacodynamics to the practice of individualized therapy
Apatinib combined with capecitabine plus temozolomide versus sunitinib in advanced gastroenteropancreatic neuroendocrine tumours: a propensity score-matched real-world study
Pharmacokinetic/pharmacodynamic optimization of antimicrobial therapy in neutropenic sepsis: a comprehensive review
High-dose continuous infusion of piperacillin/tazobactam via elastomeric pump in a pediatric patient with Kartagener syndrome: pharmacokinetic target attainment and clinical outcome
Immunotherapeutic strategies in gastroenteropancreatic neuroendocrine neoplasms: present condition and future developments
Oritavancin as sequential therapy for vancomycin-resistant Enterococcus faecium prosthetic valve endocarditis: a case report
The impact of low-volume hydration on kidney function in low-dose cisplatin therapy for biliary tract cancer: a multicentre retrospective cohort study
Risk of peripheral edema in cancer patients receiving MET inhibitors: a systematic review and meta-analysis
Taxane-induced macular oedema: disproportionality and timing analyses using FAERS and JADER
The role of gut microbiome in chemoresistance property development in colorectal cancer tissue and its novel therapeutic strategies
PqsR-specific quorum sensing inhibitors targeting Pseudomonas aeruginosa : current advances and future directions
Cytofluorimetric study of cerebrospinal fluid at staging of diffuse large B cell lymphoma
Disseminated intravascular coagulation (DIC) associated with immune checkpoint inhibitor therapy: a real-world study of the FDA adverse event reporting system
Short-term neurotoxicity trajectory in patients with thoracic cancers receiving triweekly albumin-bound paclitaxel
Effects of anthracyclines on arteriosclerosis and the protective effect of dexrazoxane in breast cancer patients
Real-world evidence for the use of olaparib in pancreatic cancer in Spanish hospitals
Volumes
2026 · 902025 · 1102024 · 732023 · 842022 · 662021 · 722020 · 602019 · 572018 · 592017 · 732016 · 892015 · 722014 · 742013 · 572012 · 682011 · 852010 · 932009 · 1322008 · 1402007 · 1472006 · 1352005 · 1182004 · 1802003 · 1142002 · 1132001 · 1622000 · 1061999 · 1141998 · 841997 · 1041996 · 821995 · 1051994 · 1141993 · 951992 · 721991 · 741990 · 831989 · 114
EUVIMED